AALL0932

Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (ALL)
Contact phone
517.364.5591
Principal investigator
Dr. Aghiad Chamdin
Trial Category
Childhood Cancers
Trial SubCategory
Leukemia
Webform